Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial

BACKGROUND: Fibroadenoma (FA) is the most common benign solid breast mass in women, with no definite method of management. Because fibroadenoma is dependent on female sex hormones and comprises hypertrophic changes at cellular levels, we investigated the effects of metformin (MF), a safe hypoglycemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Sadaf, Abedi, Mahboubeh, Saberi, Azin, Maleki-Hajiagha, Arezoo, Faiz, Firoozeh, Shahsavari, Saeed, Eslami, Bita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377455/
https://www.ncbi.nlm.nih.gov/pubmed/34416879
http://dx.doi.org/10.1186/s12902-021-00824-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377455/
https://www.ncbi.nlm.nih.gov/pubmed/34416879
http://dx.doi.org/10.1186/s12902-021-00824-4

Ejemplares similares